Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
User-Agent: * |
Title | Oligon™ Inc. - An Emerging Biotechnology |
Description | Breaking through complex Oligon™ Inc. an emerging biotechnology company develops a novel class of multimodal RNA therapeutics for the treatment of cancer & |
Keywords | N/A |
WebSite | oligon.com |
Host IP | 75.2.70.75 |
Location | United States |
Site | Rank |
US$1,494,178
Last updated: 2023-05-17 05:19:34
oligon.com has Semrush global rank of 7,083,700. oligon.com has an estimated worth of US$ 1,494,178, based on its estimated Ads revenue. oligon.com receives approximately 172,406 unique visitors each day. Its web server is located in United States, with IP address 75.2.70.75. According to SiteAdvisor, oligon.com is safe to visit. |
Purchase/Sale Value | US$1,494,178 |
Daily Ads Revenue | US$1,380 |
Monthly Ads Revenue | US$41,378 |
Yearly Ads Revenue | US$496,527 |
Daily Unique Visitors | 11,494 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
oligon.com. | A | 1800 | IP: 75.2.70.75 |
oligon.com. | A | 1800 | IP: 99.83.190.102 |
oligon.com. | NS | 3600 | NS Record: ns25.domaincontrol.com. |
oligon.com. | NS | 3600 | NS Record: ns26.domaincontrol.com. |
oligon.com. | MX | 3600 | MX Record: 0 oligon-com.mail.protection.outlook.com. |
oligon.com. | TXT | 3600 | TXT Record: v=spf1 include:spf.protection.outlook.com -all |
Contact Us Home SeekR Platform Leadership Papers, News & Events A Culture of Innovation Pipeline Breaking through complex diseases We translate genomic intelligence into multitargeting therapies Twitter Linkedin Multimodal RNA drugs to reverse resistance and improve clinical outcomes Multimodal We combine the potent binding of high performance aptamer binders with the flexible silencing power of RNAi Multitargeted SeekRs™ have the unique ability to target 4 or more pathways with a single agent Multifunctional SeekRs™ can be directed to any cell type and can be designed to influence a wide spectrum of cellular funtions and clinical phenotypes SeekR TM Platform Transformative RNA therapeutics platform Learn More SeekR TM Platform Pipeline of paradigm shifting RNA therapies across multiple indications See Full Pipeline Oligon TM is pioneering a new class of multimodal and multitargeting RNA therapies to transform outcomes for complex diseases Leadership Our Executive Leadership Team Meet |
HTTP/1.1 301 Moved Permanently Server: openresty Date: Mon, 07 Mar 2022 09:13:56 GMT Content-Type: text/html Content-Length: 166 Connection: keep-alive Location: https://oligon.com/ HTTP/2 301 server: openresty date: Mon, 07 Mar 2022 09:13:57 GMT content-type: text/html content-length: 166 location: https://www.oligon.com/ HTTP/2 200 server: openresty date: Mon, 07 Mar 2022 09:13:57 GMT content-type: text/html content-length: 17621 via: 1.1 varnish, 1.1 varnish accept-ranges: bytes age: 0 x-served-by: cache-iad-kiad7000053-IAD, cache-dub4342-DUB x-cache: MISS, MISS x-cache-hits: 0, 0 x-timer: S1646644438.656364,VS0,VE212 vary: x-wf-forwarded-proto, Accept-Encoding x-cluster-name: eu-west-1-prod-eks-15 |
Domain Name: OLIGON.COM Registry Domain ID: 1706577331_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.godaddy.com Registrar URL: http://www.godaddy.com Updated Date: 2021-10-25T21:44:05Z Creation Date: 2012-03-10T19:28:35Z Registry Expiry Date: 2024-03-10T18:28:35Z Registrar: GoDaddy.com, LLC Registrar IANA ID: 146 Registrar Abuse Contact Email: abuse@godaddy.com Registrar Abuse Contact Phone: 480-624-2505 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS25.DOMAINCONTROL.COM Name Server: NS26.DOMAINCONTROL.COM DNSSEC: unsigned >>> Last update of whois database: 2022-03-07T09:42:58Z <<< |